publications-banner
Information about pipeline products
The content contained is subject to congress/journal copyright permissions. No further reproduction is permitted without permission of the copyright owner.
Information about pipeline compounds or investigational uses of compounds does not imply FDA approval for these compounds or uses, nor does it establish the safety or efficacy of these compounds or uses. There is no guarantee that the pipeline compounds or investigational uses will receive FDA approval. Daiichi Sankyo does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling.
PublicationView
Edoxaban
Patient outcomes in very elderly patients with non-valvular atrial fibrillation - ANAFIE Registry -
Edoxaban
Venous thromboembolism in patients undergoing surgery for lung cancer: A post hoc analysis of the Cancer-VTE Registry
Pexidartinib
TURALIO® Risk Evaluation and Mitigation Strategy Program (tREMS): 3-year retrospective hepatic safety assessment
Edoxaban
Risk factors of ischemic stroke in patients with atrial fibrillation after transcatheter aortic valve implantation from the randomized ENVISAGE-TAVI AF trial
Edoxaban
Clinical effects of direct oral anticoagulants in elderly patients with a bioprosthetic valve and atrial fibrillation
HER3-DXd
Cost of early progression: Patients with epidermal growth factor receptor mutated metastatic non-small-cell lung cancer
T-DXd
Trastuzumab deruxtecan in HER2-mutant non-small-cell lung cancer: A plain language summary of the DESTINY-Lung01 study
HER3-DXd
Patritumab deruxtecan in HER2-negative breast cancer: Part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response
Edoxaban
Association of D-dimer level with thrombotic events, bleeding, and mortality in Japanese patients with solid tumors: A Cancer-VTE registry subanalysis
Edoxaban
Dose reduction of edoxaban in patients 80 years and older with atrial fibrillation: Post hoc analysis of the ENGAGE AF-TIMI 48 randomized clinical trial